Date of Proposal: October 2, 2017
Proposal Number: PRN 2017-242
Proposal Description: The New Jersey Racing Commission proposes to amend a subchapter of its rule governing Medication and Testing Procedures for racehorses. Specifically, the amendment seeks to align with current industry standards the permissible threshold levels for the naturally occurring anabolic steroids boldenone, nandrolone and testosterone when testing the blood of a racehorse. Since New Jersey adopted its anabolic steroid rule in 2010, testing procedures have advanced, and research conducted since that time supports the new thresholds. The Racing Commission also proposes to adopt a new rule that will create threshold levels for the same naturally occurring anabolic steroids – boldenone, nandrolone and testosterone – when testing the urine of a racehorse. The Commission’s proposed rule amendment and proposed new rule are designed to help ensure the health and welfare of racehorses in New Jersey, bring the State’s testing thresholds into line with current scientific research and the standards recognized and adopted by most major racing jurisdictions in North America, and protect the integrity of the sport.
Summary of Proposal: A complete summary of the proposed rule is posted on the New Jersey Racing Commission Web site at: www.nj.gov/oag/racing/proposed.html
Public Comment: Public comment on the proposed rule will be accepted until December 1, 2017.
Please direct all comments to:
Frank Zanzuccki, Executive Director
Department of Law and Public Safety
New Jersey Racing Commission
P.O. Box 088
Trenton, New Jersey 08625-0088
Follow the New Jersey Attorney General’s Office online at Twitter, Facebook, Instagram & YouTube. The social media links provided are for reference only. The New Jersey Attorney General’s Office does not endorse any non-governmental websites, companies or applications.